vocimagene amiretrorepvec and flucytosine

vocimagene amiretrorepvec and flucytosine
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2011-01-12 00:00:00
Sponsor Tocagen, Inc.;3030 Bunker Hill St.;San Diego, California, 92109
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM